BiotechTube
Home/ABLi Therapeutics/Mike Moyer
MM

Mike Moyer

Investor Relations Contact (Life Science Advisors)

ABLi Therapeutics

Therapeutic Areas

Parkinson's DiseaseNeurodegenerative Diseases

ABLi Therapeutics Pipeline

DrugIndicationPhase
RisvodetinibParkinson's DiseasePre-clinical